COVID–19 Medical Production Act
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Mar 9, 2021)
COVID-19 Medical Production Act
This bill provides additional funding for FY2021 to acquire medical supplies, vaccines, and other equipment to combat COVID-19 (i.e., coronavirus disease 2019) using authorities under the Defense Production Act of 1950. That act confers on the President a broad set of authorities to influence domestic industry to provide essential materials and goods for the national defense.
This funding is available through FY2025. Beginning in FY2023, it may be used to meet public health needs to address any pathogen determined by the President to have the potential to create a public health emergency.
What just happenedMar 9, 2021
Referred to the House Committee on Financial Services.
Who’s behind it
- Introduced in HouseMar 9, 2021
- Mar 9, 2021IntroReferralH11100
Referred to the House Committee on Financial Services.
Financial Services Committee - Mar 9, 2021IntroReferralIntro-H
Introduced in House
- Mar 9, 2021IntroReferral1000
Introduced in House